CAPTRUST Financial Advisors’s Clearside Biomedical CLSD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.6K | Hold |
87,000
| – | – | ﹤0.01% | 2400 |
|
|
2025
Q1 | $79.9K | Sell |
87,000
-14,208
| -14% | -$13K | ﹤0.01% | 2256 |
|
|
2024
Q4 | $96.1K | Buy |
101,208
+8,473
| +9% | +$8.05K | ﹤0.01% | 2207 |
|
|
2024
Q3 | $118K | Buy |
92,735
+5,735
| +7% | +$7.28K | ﹤0.01% | 2194 |
|
|
2024
Q2 | $113K | Buy |
87,000
+37,000
| +74% | +$48.1K | ﹤0.01% | 2105 |
|
|
2024
Q1 | $76.5K | Hold |
50,000
| – | – | ﹤0.01% | 2068 |
|
|
2023
Q4 | $58.5K | Hold |
50,000
| – | – | ﹤0.01% | 2578 |
|
|
2023
Q3 | $43.5K | Buy |
50,000
+25,914
| +108% | +$22.5K | ﹤0.01% | 2492 |
|
|
2023
Q2 | $27K | Buy |
24,086
+3,080
| +15% | +$3.45K | ﹤0.01% | 2455 |
|
|
2023
Q1 | $21.8K | Buy |
+21,006
| New | +$21.8K | ﹤0.01% | 2250 |
|
|
2022
Q3 | – | Sell |
-4,400
| Closed | -$6K | – | 2424 |
|
|
2022
Q2 | $6K | Buy |
4,400
+4,300
| +4,300% | +$5.86K | ﹤0.01% | 3986 |
|
|
2022
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 4938 |
|
|
2021
Q4 | $0 | Buy |
+100
| New | – | ﹤0.01% | 4776 |
|